Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)
| Market Closed - Nasdaq 05:16:01 2026-02-06 pm EST | 5-day change | 1st Jan Change | ||
| 23,031.21 PTS | +2.18% |
|
-1.84% | -0.91% |
| Nov. 21 | Vaneck BNB ETF shares expected to be approved for listing on Nasdaq | RE |
| Nov. 21 | Cheer Holding receives Nasdaq delisting notice subject to hearing request | RE |
Published on 01/09/2026 at 08:11 pm EST - Modified on 01/09/2026 at 08:16 pm EST
Jan 9 (Reuters) - Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20, 2026.
(Reporting by Rhea Rose Abraham in Bengaluru; Editing by Tom Hogue)

Highest NASDAQ Composite increases |
|
|---|---|
| +19,900.00% | |
| +15,278.70% | |
| +9,900.00% | |
| +9,900.00% | |
| +9,900.00% |
The sharpest declines in NASDAQ Composite. |
|
|---|---|
| -97.44% | |
| -99.00% | |
| -99.00% | |
| -99.00% | |
| -99.00% |
Select your edition
All financial news and data tailored to specific country editions